nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.253	0.5	CpDpCtD
Cabergoline—Parkinson's disease—Memantine—Alzheimer's disease	0.253	0.5	CpDpCtD
Cabergoline—HTR2A—Alzheimer's disease	0.105	1	CbGaD
Cabergoline—HTR2A—Donepezil—Alzheimer's disease	0.0724	0.415	CbGbCtD
Cabergoline—DRD2—Memantine—Alzheimer's disease	0.0578	0.331	CbGbCtD
Cabergoline—CYP3A4—Rivastigmine—Alzheimer's disease	0.0191	0.11	CbGbCtD
Cabergoline—CYP3A4—Donepezil—Alzheimer's disease	0.0153	0.0877	CbGbCtD
Cabergoline—CYP3A4—Galantamine—Alzheimer's disease	0.00986	0.0565	CbGbCtD
Cabergoline—HTR2C—choroid plexus—Alzheimer's disease	0.00515	0.0992	CbGeAlD
Cabergoline—DRD3—telencephalic ventricle—Alzheimer's disease	0.00271	0.0522	CbGeAlD
Cabergoline—HTR2A—choroid plexus—Alzheimer's disease	0.00258	0.0497	CbGeAlD
Cabergoline—HTR7—locus ceruleus—Alzheimer's disease	0.00256	0.0493	CbGeAlD
Cabergoline—DRD1—telencephalic ventricle—Alzheimer's disease	0.00194	0.0374	CbGeAlD
Cabergoline—HTR2A—locus ceruleus—Alzheimer's disease	0.0016	0.0307	CbGeAlD
Cabergoline—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00157	0.0303	CbGeAlD
Cabergoline—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00152	0.0293	CbGeAlD
Cabergoline—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00151	0.0291	CbGeAlD
Cabergoline—HTR2A—cerebellar cortex—Alzheimer's disease	0.0013	0.0251	CbGeAlD
Cabergoline—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00127	0.0245	CbGeAlD
Cabergoline—HTR7—telencephalic ventricle—Alzheimer's disease	0.00121	0.0234	CbGeAlD
Cabergoline—DRD2—telencephalic ventricle—Alzheimer's disease	0.00115	0.0221	CbGeAlD
Cabergoline—HTR1B—blood vessel—Alzheimer's disease	0.000779	0.015	CbGeAlD
Cabergoline—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000757	0.0146	CbGeAlD
Cabergoline—HTR1D—blood vessel—Alzheimer's disease	0.000754	0.0145	CbGeAlD
Cabergoline—DRD5—forebrain—Alzheimer's disease	0.000664	0.0128	CbGeAlD
Cabergoline—DRD5—telencephalon—Alzheimer's disease	0.00061	0.0118	CbGeAlD
Cabergoline—HTR7—blood vessel—Alzheimer's disease	0.000601	0.0116	CbGeAlD
Cabergoline—ADRA1D—forebrain—Alzheimer's disease	0.000532	0.0102	CbGeAlD
Cabergoline—DRD1—forebrain—Alzheimer's disease	0.000507	0.00977	CbGeAlD
Cabergoline—ADRA1D—telencephalon—Alzheimer's disease	0.000489	0.00942	CbGeAlD
Cabergoline—DRD1—telencephalon—Alzheimer's disease	0.000466	0.00898	CbGeAlD
Cabergoline—DRD4—brain—Alzheimer's disease	0.000418	0.00805	CbGeAlD
Cabergoline—HTR1B—forebrain—Alzheimer's disease	0.000411	0.00791	CbGeAlD
Cabergoline—HTR1D—forebrain—Alzheimer's disease	0.000398	0.00766	CbGeAlD
Cabergoline—HTR2C—forebrain—Alzheimer's disease	0.000394	0.00759	CbGeAlD
Cabergoline—ADRB1—forebrain—Alzheimer's disease	0.000387	0.00745	CbGeAlD
Cabergoline—DRD3—nervous system—Alzheimer's disease	0.000385	0.0074	CbGeAlD
Cabergoline—HTR1B—telencephalon—Alzheimer's disease	0.000378	0.00728	CbGeAlD
Cabergoline—HTR2A—blood vessel—Alzheimer's disease	0.000375	0.00721	CbGeAlD
Cabergoline—DRD3—central nervous system—Alzheimer's disease	0.00037	0.00713	CbGeAlD
Cabergoline—HTR2B—forebrain—Alzheimer's disease	0.00037	0.00713	CbGeAlD
Cabergoline—HTR1D—telencephalon—Alzheimer's disease	0.000366	0.00705	CbGeAlD
Cabergoline—HTR2C—telencephalon—Alzheimer's disease	0.000362	0.00698	CbGeAlD
Cabergoline—DRD5—nervous system—Alzheimer's disease	0.00036	0.00694	CbGeAlD
Cabergoline—ADRB1—telencephalon—Alzheimer's disease	0.000356	0.00685	CbGeAlD
Cabergoline—Pergolide—HTR2A—Alzheimer's disease	0.000347	0.28	CrCbGaD
Cabergoline—DRD5—central nervous system—Alzheimer's disease	0.000347	0.00668	CbGeAlD
Cabergoline—HTR2B—telencephalon—Alzheimer's disease	0.00034	0.00655	CbGeAlD
Cabergoline—HTR1A—forebrain—Alzheimer's disease	0.000332	0.00639	CbGeAlD
Cabergoline—Cardiac failure—Memantine—Alzheimer's disease	0.000327	0.00318	CcSEcCtD
Cabergoline—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000325	0.00315	CcSEcCtD
Cabergoline—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000321	0.00312	CcSEcCtD
Cabergoline—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000321	0.00312	CcSEcCtD
Cabergoline—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00032	0.00311	CcSEcCtD
Cabergoline—Osteoarthritis—Memantine—Alzheimer's disease	0.000319	0.0031	CcSEcCtD
Cabergoline—Pergolide—CYP2D6—Alzheimer's disease	0.000317	0.256	CrCbGaD
Cabergoline—HTR7—forebrain—Alzheimer's disease	0.000317	0.0061	CbGeAlD
Cabergoline—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000317	0.00308	CcSEcCtD
Cabergoline—Rhinitis—Galantamine—Alzheimer's disease	0.000315	0.00306	CcSEcCtD
Cabergoline—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000312	0.00304	CcSEcCtD
Cabergoline—Hallucination—Galantamine—Alzheimer's disease	0.000312	0.00304	CcSEcCtD
Cabergoline—Psychotic disorder—Memantine—Alzheimer's disease	0.000312	0.00303	CcSEcCtD
Cabergoline—Gastritis—Donepezil—Alzheimer's disease	0.000311	0.00302	CcSEcCtD
Cabergoline—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00031	0.00301	CcSEcCtD
Cabergoline—Oedema peripheral—Galantamine—Alzheimer's disease	0.000309	0.003	CcSEcCtD
Cabergoline—ADRA1A—forebrain—Alzheimer's disease	0.000306	0.00589	CbGeAlD
Cabergoline—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000305	0.00296	CcSEcCtD
Cabergoline—HTR1A—telencephalon—Alzheimer's disease	0.000305	0.00587	CbGeAlD
Cabergoline—Influenza—Donepezil—Alzheimer's disease	0.000304	0.00295	CcSEcCtD
Cabergoline—Visual impairment—Galantamine—Alzheimer's disease	0.000303	0.00294	CcSEcCtD
Cabergoline—Face oedema—Rivastigmine—Alzheimer's disease	0.000302	0.00293	CcSEcCtD
Cabergoline—Lisuride—HTR2A—Alzheimer's disease	0.000301	0.243	CrCbGaD
Cabergoline—DRD2—forebrain—Alzheimer's disease	0.0003	0.00577	CbGeAlD
Cabergoline—Blood creatinine increased—Memantine—Alzheimer's disease	0.000299	0.00291	CcSEcCtD
Cabergoline—Sweating increased—Donepezil—Alzheimer's disease	0.000296	0.00288	CcSEcCtD
Cabergoline—ADRA1B—nervous system—Alzheimer's disease	0.000295	0.00569	CbGeAlD
Cabergoline—Liver function test abnormal—Memantine—Alzheimer's disease	0.000295	0.00286	CcSEcCtD
Cabergoline—DRD3—brain—Alzheimer's disease	0.000294	0.00566	CbGeAlD
Cabergoline—Bronchitis—Donepezil—Alzheimer's disease	0.000292	0.00284	CcSEcCtD
Cabergoline—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000292	0.00283	CcSEcCtD
Cabergoline—HTR7—telencephalon—Alzheimer's disease	0.000291	0.00561	CbGeAlD
Cabergoline—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000291	0.00283	CcSEcCtD
Cabergoline—Cardiac disorder—Galantamine—Alzheimer's disease	0.000291	0.00283	CcSEcCtD
Cabergoline—ADRA1D—nervous system—Alzheimer's disease	0.000289	0.00556	CbGeAlD
Cabergoline—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000288	0.0028	CcSEcCtD
Cabergoline—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000285	0.00277	CcSEcCtD
Cabergoline—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000285	0.00277	CcSEcCtD
Cabergoline—ADRA1B—central nervous system—Alzheimer's disease	0.000284	0.00548	CbGeAlD
Cabergoline—Gastritis—Memantine—Alzheimer's disease	0.000283	0.00275	CcSEcCtD
Cabergoline—ADRA1A—telencephalon—Alzheimer's disease	0.000281	0.00541	CbGeAlD
Cabergoline—Arrhythmia—Galantamine—Alzheimer's disease	0.00028	0.00272	CcSEcCtD
Cabergoline—ADRA1D—central nervous system—Alzheimer's disease	0.000278	0.00536	CbGeAlD
Cabergoline—Weight increased—Donepezil—Alzheimer's disease	0.000277	0.00269	CcSEcCtD
Cabergoline—Gastritis—Rivastigmine—Alzheimer's disease	0.000276	0.00269	CcSEcCtD
Cabergoline—Influenza—Memantine—Alzheimer's disease	0.000276	0.00268	CcSEcCtD
Cabergoline—DRD2—telencephalon—Alzheimer's disease	0.000276	0.00531	CbGeAlD
Cabergoline—DRD5—brain—Alzheimer's disease	0.000275	0.0053	CbGeAlD
Cabergoline—Lisuride—CYP2D6—Alzheimer's disease	0.000275	0.222	CrCbGaD
Cabergoline—DRD1—nervous system—Alzheimer's disease	0.000275	0.0053	CbGeAlD
Cabergoline—Weight decreased—Donepezil—Alzheimer's disease	0.000275	0.00267	CcSEcCtD
Cabergoline—Pneumonia—Donepezil—Alzheimer's disease	0.000273	0.00265	CcSEcCtD
Cabergoline—Depression—Donepezil—Alzheimer's disease	0.00027	0.00263	CcSEcCtD
Cabergoline—Flatulence—Galantamine—Alzheimer's disease	0.000269	0.00262	CcSEcCtD
Cabergoline—Sweating increased—Memantine—Alzheimer's disease	0.000269	0.00261	CcSEcCtD
Cabergoline—Tension—Galantamine—Alzheimer's disease	0.000268	0.00261	CcSEcCtD
Cabergoline—ADRA2C—telencephalon—Alzheimer's disease	0.000268	0.00516	CbGeAlD
Cabergoline—Nervousness—Galantamine—Alzheimer's disease	0.000265	0.00258	CcSEcCtD
Cabergoline—Bronchitis—Memantine—Alzheimer's disease	0.000265	0.00258	CcSEcCtD
Cabergoline—DRD1—central nervous system—Alzheimer's disease	0.000265	0.0051	CbGeAlD
Cabergoline—Back pain—Galantamine—Alzheimer's disease	0.000264	0.00257	CcSEcCtD
Cabergoline—Urinary tract infection—Donepezil—Alzheimer's disease	0.000263	0.00256	CcSEcCtD
Cabergoline—Sweating increased—Rivastigmine—Alzheimer's disease	0.000263	0.00256	CcSEcCtD
Cabergoline—Muscle spasms—Galantamine—Alzheimer's disease	0.000263	0.00255	CcSEcCtD
Cabergoline—Bronchitis—Rivastigmine—Alzheimer's disease	0.00026	0.00252	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000256	0.00249	CcSEcCtD
Cabergoline—Epistaxis—Donepezil—Alzheimer's disease	0.000256	0.00248	CcSEcCtD
Cabergoline—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000254	0.00246	CcSEcCtD
Cabergoline—Weight increased—Memantine—Alzheimer's disease	0.000251	0.00244	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000251	0.00244	CcSEcCtD
Cabergoline—Weight decreased—Memantine—Alzheimer's disease	0.00025	0.00243	CcSEcCtD
Cabergoline—Pneumonia—Memantine—Alzheimer's disease	0.000247	0.0024	CcSEcCtD
Cabergoline—Malaise—Galantamine—Alzheimer's disease	0.000246	0.00239	CcSEcCtD
Cabergoline—Weight increased—Rivastigmine—Alzheimer's disease	0.000246	0.00239	CcSEcCtD
Cabergoline—Vertigo—Galantamine—Alzheimer's disease	0.000246	0.00239	CcSEcCtD
Cabergoline—Depression—Memantine—Alzheimer's disease	0.000245	0.00238	CcSEcCtD
Cabergoline—Syncope—Galantamine—Alzheimer's disease	0.000245	0.00238	CcSEcCtD
Cabergoline—Weight decreased—Rivastigmine—Alzheimer's disease	0.000244	0.00237	CcSEcCtD
Cabergoline—Rhinitis—Donepezil—Alzheimer's disease	0.000244	0.00237	CcSEcCtD
Cabergoline—Pneumonia—Rivastigmine—Alzheimer's disease	0.000242	0.00235	CcSEcCtD
Cabergoline—Hallucination—Donepezil—Alzheimer's disease	0.000242	0.00235	CcSEcCtD
Cabergoline—Palpitations—Galantamine—Alzheimer's disease	0.000241	0.00235	CcSEcCtD
Cabergoline—Loss of consciousness—Galantamine—Alzheimer's disease	0.00024	0.00233	CcSEcCtD
Cabergoline—Depression—Rivastigmine—Alzheimer's disease	0.00024	0.00233	CcSEcCtD
Cabergoline—Oedema peripheral—Donepezil—Alzheimer's disease	0.00024	0.00233	CcSEcCtD
Cabergoline—Urinary tract infection—Memantine—Alzheimer's disease	0.000239	0.00232	CcSEcCtD
Cabergoline—Hypertension—Galantamine—Alzheimer's disease	0.000236	0.00229	CcSEcCtD
Cabergoline—Visual impairment—Donepezil—Alzheimer's disease	0.000234	0.00228	CcSEcCtD
Cabergoline—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000234	0.00227	CcSEcCtD
Cabergoline—Arthralgia—Galantamine—Alzheimer's disease	0.000233	0.00226	CcSEcCtD
Cabergoline—ADRA2A—forebrain—Alzheimer's disease	0.000232	0.00448	CbGeAlD
Cabergoline—Epistaxis—Memantine—Alzheimer's disease	0.000232	0.00226	CcSEcCtD
Cabergoline—Anxiety—Galantamine—Alzheimer's disease	0.000232	0.00225	CcSEcCtD
Cabergoline—Discomfort—Galantamine—Alzheimer's disease	0.00023	0.00223	CcSEcCtD
Cabergoline—Dry mouth—Galantamine—Alzheimer's disease	0.000228	0.00221	CcSEcCtD
Cabergoline—Epistaxis—Rivastigmine—Alzheimer's disease	0.000227	0.00221	CcSEcCtD
Cabergoline—ADRA1B—brain—Alzheimer's disease	0.000226	0.00435	CbGeAlD
Cabergoline—Confusional state—Galantamine—Alzheimer's disease	0.000225	0.00219	CcSEcCtD
Cabergoline—HTR2A—embryo—Alzheimer's disease	0.000223	0.0043	CbGeAlD
Cabergoline—HTR1B—nervous system—Alzheimer's disease	0.000223	0.0043	CbGeAlD
Cabergoline—Rhinitis—Memantine—Alzheimer's disease	0.000221	0.00215	CcSEcCtD
Cabergoline—ADRA1D—brain—Alzheimer's disease	0.000221	0.00425	CbGeAlD
Cabergoline—Hallucination—Memantine—Alzheimer's disease	0.00022	0.00214	CcSEcCtD
Cabergoline—Shock—Galantamine—Alzheimer's disease	0.000219	0.00213	CcSEcCtD
Cabergoline—Oedema peripheral—Memantine—Alzheimer's disease	0.000218	0.00211	CcSEcCtD
Cabergoline—Arrhythmia—Donepezil—Alzheimer's disease	0.000217	0.00211	CcSEcCtD
Cabergoline—Rhinitis—Rivastigmine—Alzheimer's disease	0.000217	0.00211	CcSEcCtD
Cabergoline—HTR1D—nervous system—Alzheimer's disease	0.000216	0.00416	CbGeAlD
Cabergoline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000216	0.0021	CcSEcCtD
Cabergoline—Hallucination—Rivastigmine—Alzheimer's disease	0.000215	0.00209	CcSEcCtD
Cabergoline—Alopecia—Donepezil—Alzheimer's disease	0.000215	0.00209	CcSEcCtD
Cabergoline—HTR1B—central nervous system—Alzheimer's disease	0.000215	0.00414	CbGeAlD
Cabergoline—HTR2C—nervous system—Alzheimer's disease	0.000214	0.00412	CbGeAlD
Cabergoline—ADRA2A—telencephalon—Alzheimer's disease	0.000214	0.00412	CbGeAlD
Cabergoline—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000213	0.00207	CcSEcCtD
Cabergoline—Visual impairment—Memantine—Alzheimer's disease	0.000213	0.00207	CcSEcCtD
Cabergoline—Anorexia—Galantamine—Alzheimer's disease	0.000213	0.00207	CcSEcCtD
Cabergoline—DRD1—brain—Alzheimer's disease	0.00021	0.00405	CbGeAlD
Cabergoline—ADRB1—nervous system—Alzheimer's disease	0.00021	0.00404	CbGeAlD
Cabergoline—Flatulence—Donepezil—Alzheimer's disease	0.000209	0.00203	CcSEcCtD
Cabergoline—Hypotension—Galantamine—Alzheimer's disease	0.000208	0.00203	CcSEcCtD
Cabergoline—Visual impairment—Rivastigmine—Alzheimer's disease	0.000208	0.00202	CcSEcCtD
Cabergoline—HTR1D—central nervous system—Alzheimer's disease	0.000208	0.004	CbGeAlD
Cabergoline—Tension—Donepezil—Alzheimer's disease	0.000208	0.00202	CcSEcCtD
Cabergoline—HTR2C—central nervous system—Alzheimer's disease	0.000206	0.00397	CbGeAlD
Cabergoline—Nervousness—Donepezil—Alzheimer's disease	0.000206	0.002	CcSEcCtD
Cabergoline—Cardiac disorder—Memantine—Alzheimer's disease	0.000205	0.00199	CcSEcCtD
Cabergoline—Back pain—Donepezil—Alzheimer's disease	0.000205	0.00199	CcSEcCtD
Cabergoline—Muscle spasms—Donepezil—Alzheimer's disease	0.000204	0.00198	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000203	0.00197	CcSEcCtD
Cabergoline—ADRB1—central nervous system—Alzheimer's disease	0.000202	0.00389	CbGeAlD
Cabergoline—Insomnia—Galantamine—Alzheimer's disease	0.000202	0.00196	CcSEcCtD
Cabergoline—HTR2B—nervous system—Alzheimer's disease	0.000201	0.00387	CbGeAlD
Cabergoline—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000201	0.00195	CcSEcCtD
Cabergoline—Paraesthesia—Galantamine—Alzheimer's disease	0.0002	0.00195	CcSEcCtD
Cabergoline—Somnolence—Galantamine—Alzheimer's disease	0.000198	0.00193	CcSEcCtD
Cabergoline—HTR2A—forebrain—Alzheimer's disease	0.000198	0.00381	CbGeAlD
Cabergoline—Arrhythmia—Memantine—Alzheimer's disease	0.000197	0.00192	CcSEcCtD
Cabergoline—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000196	0.00191	CcSEcCtD
Cabergoline—Dyspepsia—Galantamine—Alzheimer's disease	0.000196	0.00191	CcSEcCtD
Cabergoline—Alopecia—Memantine—Alzheimer's disease	0.000195	0.0019	CcSEcCtD
Cabergoline—Decreased appetite—Galantamine—Alzheimer's disease	0.000194	0.00188	CcSEcCtD
Cabergoline—HTR2B—central nervous system—Alzheimer's disease	0.000193	0.00372	CbGeAlD
Cabergoline—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000193	0.00188	CcSEcCtD
Cabergoline—Fatigue—Galantamine—Alzheimer's disease	0.000192	0.00187	CcSEcCtD
Cabergoline—Malaise—Donepezil—Alzheimer's disease	0.000191	0.00186	CcSEcCtD
Cabergoline—Alopecia—Rivastigmine—Alzheimer's disease	0.000191	0.00186	CcSEcCtD
Cabergoline—Constipation—Galantamine—Alzheimer's disease	0.000191	0.00185	CcSEcCtD
Cabergoline—Vertigo—Donepezil—Alzheimer's disease	0.00019	0.00185	CcSEcCtD
Cabergoline—Syncope—Donepezil—Alzheimer's disease	0.00019	0.00185	CcSEcCtD
Cabergoline—Flatulence—Memantine—Alzheimer's disease	0.000189	0.00184	CcSEcCtD
Cabergoline—Tension—Memantine—Alzheimer's disease	0.000189	0.00183	CcSEcCtD
Cabergoline—Nervousness—Memantine—Alzheimer's disease	0.000187	0.00181	CcSEcCtD
Cabergoline—Loss of consciousness—Donepezil—Alzheimer's disease	0.000186	0.00181	CcSEcCtD
Cabergoline—Back pain—Memantine—Alzheimer's disease	0.000186	0.00181	CcSEcCtD
Cabergoline—Flatulence—Rivastigmine—Alzheimer's disease	0.000185	0.0018	CcSEcCtD
Cabergoline—Tension—Rivastigmine—Alzheimer's disease	0.000185	0.00179	CcSEcCtD
Cabergoline—Feeling abnormal—Galantamine—Alzheimer's disease	0.000184	0.00179	CcSEcCtD
Cabergoline—Hypertension—Donepezil—Alzheimer's disease	0.000183	0.00178	CcSEcCtD
Cabergoline—Nervousness—Rivastigmine—Alzheimer's disease	0.000183	0.00178	CcSEcCtD
Cabergoline—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000182	0.00177	CcSEcCtD
Cabergoline—Back pain—Rivastigmine—Alzheimer's disease	0.000182	0.00177	CcSEcCtD
Cabergoline—HTR2A—telencephalon—Alzheimer's disease	0.000182	0.0035	CbGeAlD
Cabergoline—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000181	0.00176	CcSEcCtD
Cabergoline—Arthralgia—Donepezil—Alzheimer's disease	0.00018	0.00175	CcSEcCtD
Cabergoline—HTR1A—nervous system—Alzheimer's disease	0.00018	0.00347	CbGeAlD
Cabergoline—Anxiety—Donepezil—Alzheimer's disease	0.00018	0.00175	CcSEcCtD
Cabergoline—Ill-defined disorder—Memantine—Alzheimer's disease	0.000178	0.00173	CcSEcCtD
Cabergoline—Discomfort—Donepezil—Alzheimer's disease	0.000178	0.00173	CcSEcCtD
Cabergoline—Dry mouth—Donepezil—Alzheimer's disease	0.000176	0.00171	CcSEcCtD
Cabergoline—Abdominal pain—Galantamine—Alzheimer's disease	0.000176	0.00171	CcSEcCtD
Cabergoline—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000175	0.0017	CcSEcCtD
Cabergoline—Confusional state—Donepezil—Alzheimer's disease	0.000174	0.00169	CcSEcCtD
Cabergoline—Malaise—Memantine—Alzheimer's disease	0.000173	0.00168	CcSEcCtD
Cabergoline—HTR1A—central nervous system—Alzheimer's disease	0.000173	0.00334	CbGeAlD
Cabergoline—Oedema—Donepezil—Alzheimer's disease	0.000173	0.00168	CcSEcCtD
Cabergoline—Vertigo—Memantine—Alzheimer's disease	0.000173	0.00168	CcSEcCtD
Cabergoline—Syncope—Memantine—Alzheimer's disease	0.000172	0.00168	CcSEcCtD
Cabergoline—HTR7—nervous system—Alzheimer's disease	0.000172	0.00331	CbGeAlD
Cabergoline—HTR1B—brain—Alzheimer's disease	0.000171	0.00328	CbGeAlD
Cabergoline—Shock—Donepezil—Alzheimer's disease	0.00017	0.00165	CcSEcCtD
Cabergoline—Palpitations—Memantine—Alzheimer's disease	0.00017	0.00165	CcSEcCtD
Cabergoline—Malaise—Rivastigmine—Alzheimer's disease	0.00017	0.00165	CcSEcCtD
Cabergoline—HTR1A—cerebellum—Alzheimer's disease	0.000169	0.00326	CbGeAlD
Cabergoline—Vertigo—Rivastigmine—Alzheimer's disease	0.000169	0.00164	CcSEcCtD
Cabergoline—Loss of consciousness—Memantine—Alzheimer's disease	0.000169	0.00164	CcSEcCtD
Cabergoline—Syncope—Rivastigmine—Alzheimer's disease	0.000169	0.00164	CcSEcCtD
Cabergoline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000167	0.00162	CcSEcCtD
Cabergoline—Palpitations—Rivastigmine—Alzheimer's disease	0.000166	0.00162	CcSEcCtD
Cabergoline—Hypertension—Memantine—Alzheimer's disease	0.000166	0.00161	CcSEcCtD
Cabergoline—ADRA1A—nervous system—Alzheimer's disease	0.000166	0.0032	CbGeAlD
Cabergoline—HTR7—central nervous system—Alzheimer's disease	0.000166	0.00319	CbGeAlD
Cabergoline—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000165	0.00161	CcSEcCtD
Cabergoline—HTR1D—brain—Alzheimer's disease	0.000165	0.00318	CbGeAlD
Cabergoline—Anorexia—Donepezil—Alzheimer's disease	0.000165	0.0016	CcSEcCtD
Cabergoline—Hypersensitivity—Galantamine—Alzheimer's disease	0.000164	0.0016	CcSEcCtD
Cabergoline—Arthralgia—Memantine—Alzheimer's disease	0.000164	0.00159	CcSEcCtD
Cabergoline—HTR2C—brain—Alzheimer's disease	0.000163	0.00315	CbGeAlD
Cabergoline—Anxiety—Memantine—Alzheimer's disease	0.000163	0.00159	CcSEcCtD
Cabergoline—DRD2—nervous system—Alzheimer's disease	0.000163	0.00313	CbGeAlD
Cabergoline—Hypertension—Rivastigmine—Alzheimer's disease	0.000162	0.00158	CcSEcCtD
Cabergoline—HTR7—cerebellum—Alzheimer's disease	0.000162	0.00312	CbGeAlD
Cabergoline—Discomfort—Memantine—Alzheimer's disease	0.000162	0.00157	CcSEcCtD
Cabergoline—Hypotension—Donepezil—Alzheimer's disease	0.000162	0.00157	CcSEcCtD
Cabergoline—ADRB1—brain—Alzheimer's disease	0.00016	0.00309	CbGeAlD
Cabergoline—Arthralgia—Rivastigmine—Alzheimer's disease	0.00016	0.00156	CcSEcCtD
Cabergoline—Dry mouth—Memantine—Alzheimer's disease	0.00016	0.00156	CcSEcCtD
Cabergoline—Asthenia—Galantamine—Alzheimer's disease	0.00016	0.00155	CcSEcCtD
Cabergoline—ADRA1A—central nervous system—Alzheimer's disease	0.00016	0.00308	CbGeAlD
Cabergoline—Anxiety—Rivastigmine—Alzheimer's disease	0.00016	0.00155	CcSEcCtD
Cabergoline—Confusional state—Memantine—Alzheimer's disease	0.000158	0.00154	CcSEcCtD
Cabergoline—Discomfort—Rivastigmine—Alzheimer's disease	0.000158	0.00154	CcSEcCtD
Cabergoline—ADRA2C—nervous system—Alzheimer's disease	0.000158	0.00305	CbGeAlD
Cabergoline—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000157	0.00153	CcSEcCtD
Cabergoline—Oedema—Memantine—Alzheimer's disease	0.000157	0.00152	CcSEcCtD
Cabergoline—Dry mouth—Rivastigmine—Alzheimer's disease	0.000157	0.00152	CcSEcCtD
Cabergoline—DRD2—central nervous system—Alzheimer's disease	0.000157	0.00302	CbGeAlD
Cabergoline—Insomnia—Donepezil—Alzheimer's disease	0.000156	0.00152	CcSEcCtD
Cabergoline—ADRA1A—cerebellum—Alzheimer's disease	0.000156	0.00301	CbGeAlD
Cabergoline—Paraesthesia—Donepezil—Alzheimer's disease	0.000155	0.00151	CcSEcCtD
Cabergoline—Confusional state—Rivastigmine—Alzheimer's disease	0.000155	0.0015	CcSEcCtD
Cabergoline—Shock—Memantine—Alzheimer's disease	0.000154	0.0015	CcSEcCtD
Cabergoline—Dyspnoea—Donepezil—Alzheimer's disease	0.000154	0.0015	CcSEcCtD
Cabergoline—Somnolence—Donepezil—Alzheimer's disease	0.000154	0.00149	CcSEcCtD
Cabergoline—HTR2B—brain—Alzheimer's disease	0.000154	0.00296	CbGeAlD
Cabergoline—Oedema—Rivastigmine—Alzheimer's disease	0.000154	0.00149	CcSEcCtD
Cabergoline—DRD2—cerebellum—Alzheimer's disease	0.000153	0.00295	CbGeAlD
Cabergoline—Diarrhoea—Galantamine—Alzheimer's disease	0.000153	0.00148	CcSEcCtD
Cabergoline—ADRA2C—central nervous system—Alzheimer's disease	0.000152	0.00293	CbGeAlD
Cabergoline—Dyspepsia—Donepezil—Alzheimer's disease	0.000152	0.00148	CcSEcCtD
Cabergoline—Hyperhidrosis—Memantine—Alzheimer's disease	0.000152	0.00147	CcSEcCtD
Cabergoline—Shock—Rivastigmine—Alzheimer's disease	0.000151	0.00147	CcSEcCtD
Cabergoline—Decreased appetite—Donepezil—Alzheimer's disease	0.00015	0.00146	CcSEcCtD
Cabergoline—Anorexia—Memantine—Alzheimer's disease	0.00015	0.00145	CcSEcCtD
Cabergoline—Fatigue—Donepezil—Alzheimer's disease	0.000149	0.00145	CcSEcCtD
Cabergoline—ADRA2C—cerebellum—Alzheimer's disease	0.000149	0.00287	CbGeAlD
Cabergoline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000148	0.00144	CcSEcCtD
Cabergoline—Constipation—Donepezil—Alzheimer's disease	0.000148	0.00144	CcSEcCtD
Cabergoline—Pain—Donepezil—Alzheimer's disease	0.000148	0.00144	CcSEcCtD
Cabergoline—Dizziness—Galantamine—Alzheimer's disease	0.000147	0.00143	CcSEcCtD
Cabergoline—Hypotension—Memantine—Alzheimer's disease	0.000147	0.00142	CcSEcCtD
Cabergoline—Anorexia—Rivastigmine—Alzheimer's disease	0.000146	0.00142	CcSEcCtD
Cabergoline—Hypotension—Rivastigmine—Alzheimer's disease	0.000143	0.00139	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000143	0.00139	CcSEcCtD
Cabergoline—Feeling abnormal—Donepezil—Alzheimer's disease	0.000142	0.00138	CcSEcCtD
Cabergoline—Insomnia—Memantine—Alzheimer's disease	0.000142	0.00138	CcSEcCtD
Cabergoline—Vomiting—Galantamine—Alzheimer's disease	0.000142	0.00138	CcSEcCtD
Cabergoline—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000141	0.00137	CcSEcCtD
Cabergoline—Paraesthesia—Memantine—Alzheimer's disease	0.000141	0.00137	CcSEcCtD
Cabergoline—Rash—Galantamine—Alzheimer's disease	0.000141	0.00137	CcSEcCtD
Cabergoline—Dermatitis—Galantamine—Alzheimer's disease	0.00014	0.00137	CcSEcCtD
Cabergoline—Dyspnoea—Memantine—Alzheimer's disease	0.00014	0.00136	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00014	0.00136	CcSEcCtD
Cabergoline—Headache—Galantamine—Alzheimer's disease	0.00014	0.00136	CcSEcCtD
Cabergoline—Somnolence—Memantine—Alzheimer's disease	0.00014	0.00136	CcSEcCtD
Cabergoline—Insomnia—Rivastigmine—Alzheimer's disease	0.000139	0.00135	CcSEcCtD
Cabergoline—Dyspepsia—Memantine—Alzheimer's disease	0.000138	0.00134	CcSEcCtD
Cabergoline—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000138	0.00134	CcSEcCtD
Cabergoline—HTR1A—brain—Alzheimer's disease	0.000138	0.00265	CbGeAlD
Cabergoline—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000137	0.00133	CcSEcCtD
Cabergoline—Abdominal pain—Donepezil—Alzheimer's disease	0.000137	0.00133	CcSEcCtD
Cabergoline—Somnolence—Rivastigmine—Alzheimer's disease	0.000136	0.00133	CcSEcCtD
Cabergoline—Decreased appetite—Memantine—Alzheimer's disease	0.000136	0.00133	CcSEcCtD
Cabergoline—Fatigue—Memantine—Alzheimer's disease	0.000135	0.00131	CcSEcCtD
Cabergoline—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000135	0.00131	CcSEcCtD
Cabergoline—Constipation—Memantine—Alzheimer's disease	0.000134	0.0013	CcSEcCtD
Cabergoline—Pain—Memantine—Alzheimer's disease	0.000134	0.0013	CcSEcCtD
Cabergoline—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000133	0.0013	CcSEcCtD
Cabergoline—Nausea—Galantamine—Alzheimer's disease	0.000132	0.00129	CcSEcCtD
Cabergoline—Fatigue—Rivastigmine—Alzheimer's disease	0.000132	0.00129	CcSEcCtD
Cabergoline—HTR7—brain—Alzheimer's disease	0.000132	0.00253	CbGeAlD
Cabergoline—Constipation—Rivastigmine—Alzheimer's disease	0.000131	0.00128	CcSEcCtD
Cabergoline—Pain—Rivastigmine—Alzheimer's disease	0.000131	0.00128	CcSEcCtD
Cabergoline—Feeling abnormal—Memantine—Alzheimer's disease	0.000129	0.00126	CcSEcCtD
Cabergoline—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000128	0.00125	CcSEcCtD
Cabergoline—Hypersensitivity—Donepezil—Alzheimer's disease	0.000127	0.00124	CcSEcCtD
Cabergoline—ADRA1A—brain—Alzheimer's disease	0.000127	0.00244	CbGeAlD
Cabergoline—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000127	0.00123	CcSEcCtD
Cabergoline—ADRA2A—nervous system—Alzheimer's disease	0.000126	0.00243	CbGeAlD
Cabergoline—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000126	0.00122	CcSEcCtD
Cabergoline—DRD2—brain—Alzheimer's disease	0.000124	0.00239	CbGeAlD
Cabergoline—Abdominal pain—Memantine—Alzheimer's disease	0.000124	0.00121	CcSEcCtD
Cabergoline—Asthenia—Donepezil—Alzheimer's disease	0.000124	0.00121	CcSEcCtD
Cabergoline—Pruritus—Donepezil—Alzheimer's disease	0.000122	0.00119	CcSEcCtD
Cabergoline—ADRA2A—central nervous system—Alzheimer's disease	0.000121	0.00234	CbGeAlD
Cabergoline—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000121	0.00118	CcSEcCtD
Cabergoline—ADRA2C—brain—Alzheimer's disease	0.000121	0.00233	CbGeAlD
Cabergoline—ADRA2A—cerebellum—Alzheimer's disease	0.000119	0.00229	CbGeAlD
Cabergoline—Diarrhoea—Donepezil—Alzheimer's disease	0.000118	0.00115	CcSEcCtD
Cabergoline—Hypersensitivity—Memantine—Alzheimer's disease	0.000116	0.00112	CcSEcCtD
Cabergoline—Dizziness—Donepezil—Alzheimer's disease	0.000114	0.00111	CcSEcCtD
Cabergoline—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000113	0.0011	CcSEcCtD
Cabergoline—Asthenia—Memantine—Alzheimer's disease	0.000113	0.00109	CcSEcCtD
Cabergoline—Pruritus—Memantine—Alzheimer's disease	0.000111	0.00108	CcSEcCtD
Cabergoline—Asthenia—Rivastigmine—Alzheimer's disease	0.00011	0.00107	CcSEcCtD
Cabergoline—Vomiting—Donepezil—Alzheimer's disease	0.00011	0.00107	CcSEcCtD
Cabergoline—Rash—Donepezil—Alzheimer's disease	0.000109	0.00106	CcSEcCtD
Cabergoline—Dermatitis—Donepezil—Alzheimer's disease	0.000109	0.00106	CcSEcCtD
Cabergoline—Pruritus—Rivastigmine—Alzheimer's disease	0.000109	0.00106	CcSEcCtD
Cabergoline—Headache—Donepezil—Alzheimer's disease	0.000108	0.00105	CcSEcCtD
Cabergoline—Diarrhoea—Memantine—Alzheimer's disease	0.000107	0.00104	CcSEcCtD
Cabergoline—HTR2A—nervous system—Alzheimer's disease	0.000107	0.00207	CbGeAlD
Cabergoline—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000105	0.00102	CcSEcCtD
Cabergoline—Dizziness—Memantine—Alzheimer's disease	0.000104	0.00101	CcSEcCtD
Cabergoline—HTR2A—central nervous system—Alzheimer's disease	0.000103	0.00199	CbGeAlD
Cabergoline—Nausea—Donepezil—Alzheimer's disease	0.000103	0.000998	CcSEcCtD
Cabergoline—Dizziness—Rivastigmine—Alzheimer's disease	0.000102	0.000986	CcSEcCtD
Cabergoline—HTR2A—cerebellum—Alzheimer's disease	0.000101	0.00194	CbGeAlD
Cabergoline—Vomiting—Memantine—Alzheimer's disease	9.98e-05	0.00097	CcSEcCtD
Cabergoline—CYP3A4—nervous system—Alzheimer's disease	9.93e-05	0.00191	CbGeAlD
Cabergoline—Rash—Memantine—Alzheimer's disease	9.89e-05	0.000961	CcSEcCtD
Cabergoline—Dermatitis—Memantine—Alzheimer's disease	9.89e-05	0.000961	CcSEcCtD
Cabergoline—Headache—Memantine—Alzheimer's disease	9.83e-05	0.000955	CcSEcCtD
Cabergoline—Vomiting—Rivastigmine—Alzheimer's disease	9.76e-05	0.000949	CcSEcCtD
Cabergoline—Rash—Rivastigmine—Alzheimer's disease	9.68e-05	0.000941	CcSEcCtD
Cabergoline—Dermatitis—Rivastigmine—Alzheimer's disease	9.67e-05	0.00094	CcSEcCtD
Cabergoline—ADRA2A—brain—Alzheimer's disease	9.65e-05	0.00186	CbGeAlD
Cabergoline—Headache—Rivastigmine—Alzheimer's disease	9.62e-05	0.000935	CcSEcCtD
Cabergoline—CYP3A4—central nervous system—Alzheimer's disease	9.56e-05	0.00184	CbGeAlD
Cabergoline—Nausea—Memantine—Alzheimer's disease	9.32e-05	0.000906	CcSEcCtD
Cabergoline—Nausea—Rivastigmine—Alzheimer's disease	9.12e-05	0.000886	CcSEcCtD
Cabergoline—HTR2A—brain—Alzheimer's disease	8.2e-05	0.00158	CbGeAlD
Cabergoline—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	2.13e-06	3.62e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.13e-06	3.62e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	2.13e-06	3.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.13e-06	3.61e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	2.11e-06	3.59e-05	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.11e-06	3.59e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	2.1e-06	3.57e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.1e-06	3.57e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	2.1e-06	3.56e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	2.1e-06	3.56e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.09e-06	3.56e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.09e-06	3.56e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	2.09e-06	3.55e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.09e-06	3.55e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	2.09e-06	3.55e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.08e-06	3.54e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.08e-06	3.54e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	2.08e-06	3.53e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.08e-06	3.53e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	2.07e-06	3.51e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.05e-06	3.48e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	2.04e-06	3.47e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.04e-06	3.47e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.04e-06	3.46e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.03e-06	3.44e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.01e-06	3.42e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.01e-06	3.42e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.01e-06	3.42e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.01e-06	3.41e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2e-06	3.4e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—INS—Alzheimer's disease	2e-06	3.4e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2e-06	3.39e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.99e-06	3.39e-05	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.99e-06	3.38e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	1.99e-06	3.38e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.98e-06	3.36e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	1.98e-06	3.36e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.97e-06	3.35e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.97e-06	3.34e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	1.97e-06	3.34e-05	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	1.96e-06	3.34e-05	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.96e-06	3.34e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.96e-06	3.33e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.95e-06	3.32e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	1.95e-06	3.31e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	1.95e-06	3.31e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	1.94e-06	3.3e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.94e-06	3.29e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.94e-06	3.29e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.93e-06	3.29e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.93e-06	3.29e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	1.93e-06	3.28e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	1.93e-06	3.28e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	1.93e-06	3.28e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.93e-06	3.28e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.93e-06	3.27e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.92e-06	3.26e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.92e-06	3.26e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.91e-06	3.24e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.91e-06	3.24e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.9e-06	3.23e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TP53—Alzheimer's disease	1.9e-06	3.23e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	1.9e-06	3.23e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.9e-06	3.22e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.89e-06	3.21e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—NOS3—Alzheimer's disease	1.88e-06	3.19e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.87e-06	3.18e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.86e-06	3.17e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-06	3.16e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.81e-06	3.08e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.81e-06	3.08e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.81e-06	3.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.8e-06	3.06e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.79e-06	3.04e-05	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.79e-06	3.04e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.79e-06	3.04e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.79e-06	3.04e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.78e-06	3.03e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.78e-06	3.03e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-06	3.03e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.77e-06	3.01e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.77e-06	3.01e-05	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.77e-06	3.01e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.77e-06	3.01e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.77e-06	3.01e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.76e-06	2.99e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.76e-06	2.99e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.76e-06	2.98e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.75e-06	2.98e-05	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	2.97e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-06	2.96e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.74e-06	2.96e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	1.73e-06	2.95e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.73e-06	2.95e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.73e-06	2.94e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.73e-06	2.93e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	1.72e-06	2.93e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.72e-06	2.92e-05	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.71e-06	2.91e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-06	2.9e-05	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.7e-06	2.89e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.7e-06	2.88e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-06	2.87e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.69e-06	2.87e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.68e-06	2.86e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.68e-06	2.85e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.67e-06	2.84e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.67e-06	2.84e-05	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.66e-06	2.81e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-06	2.8e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-06	2.8e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.64e-06	2.79e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.63e-06	2.77e-05	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.63e-06	2.77e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.63e-06	2.77e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-06	2.77e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.62e-06	2.76e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.62e-06	2.76e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.61e-06	2.74e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-06	2.74e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.61e-06	2.74e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-06	2.73e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.6e-06	2.73e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	1.59e-06	2.71e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	2.7e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.57e-06	2.67e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.56e-06	2.65e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.55e-06	2.64e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-06	2.63e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.55e-06	2.63e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.54e-06	2.61e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.52e-06	2.57e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.52e-06	2.57e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.51e-06	2.56e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.5e-06	2.56e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.5e-06	2.55e-05	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.5e-06	2.55e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.49e-06	2.53e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.49e-06	2.53e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.48e-06	2.52e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.48e-06	2.51e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.48e-06	2.51e-05	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.48e-06	2.51e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	2.5e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	2.49e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	2.49e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.46e-06	2.48e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.46e-06	2.47e-05	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	2.46e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.44e-06	2.44e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.43e-06	2.44e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	2.43e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.43e-06	2.42e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.42e-06	2.42e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.4e-06	2.39e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.4e-06	2.38e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.39e-06	2.37e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.39e-06	2.37e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.38e-06	2.35e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-06	2.33e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.37e-06	2.32e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.37e-06	2.32e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-06	2.32e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	2.29e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.35e-06	2.29e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.34e-06	2.29e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	2.28e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-06	2.28e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	2.28e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.33e-06	2.27e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.33e-06	2.26e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.32e-06	2.25e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.32e-06	2.24e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	2.24e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.31e-06	2.23e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	2.23e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.31e-06	2.22e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.29e-06	2.18e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.28e-06	2.17e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.27e-06	2.16e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.26e-06	2.15e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-06	2.15e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	2.14e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.25e-06	2.12e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.25e-06	2.12e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-06	2.11e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	2.1e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.23e-06	2.09e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.23e-06	2.08e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.22e-06	2.08e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.22e-06	2.08e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	2.07e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.2e-06	2.05e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-06	2.01e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-06	1.97e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.16e-06	1.97e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.15e-06	1.95e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.94e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.94e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-06	1.94e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.14e-06	1.93e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	1.92e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.13e-06	1.92e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	1.91e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.9e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.89e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.09e-06	1.85e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.84e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.07e-06	1.82e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-06	1.81e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.07e-06	1.81e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.06e-06	1.8e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.06e-06	1.8e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	1.79e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	1.79e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.05e-06	1.79e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.04e-06	1.77e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-06	1.76e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	1.76e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.03e-06	1.75e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.73e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.95e-07	1.69e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	9.9e-07	1.68e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	9.63e-07	1.64e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	9.6e-07	1.63e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—Alzheimer's disease	9.54e-07	1.62e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	9.51e-07	1.62e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	9.48e-07	1.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.39e-07	1.6e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	9.39e-07	1.6e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARG—Alzheimer's disease	9.3e-07	1.58e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	9.2e-07	1.56e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.18e-07	1.56e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.13e-07	1.55e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—INS—Alzheimer's disease	9.12e-07	1.55e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	8.88e-07	1.51e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	8.74e-07	1.49e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.74e-07	1.48e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—Alzheimer's disease	8.63e-07	1.47e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.6e-07	1.46e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	8.54e-07	1.45e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	8.42e-07	1.43e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	8.06e-07	1.37e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NOS3—Alzheimer's disease	8e-07	1.36e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.93e-07	1.35e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	7.82e-07	1.33e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.76e-07	1.32e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.31e-07	1.24e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	7.21e-07	1.23e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.68e-07	6.25e-06	CbGpPWpGaD
